Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,650 | 1,180 | 1,790 | 280 | 270 |
| TOTAL | $1,650 | $1,180 | $1,790 | $280 | $270 |
| Non-Current Assets | |||||
| Investments And Advances | 130 | 240 | 210 | 260 | 370 |
| Other Non-Current Assets | 5,960 | 5,600 | 5,840 | 11,570 | 10,100 |
| TOTAL | $6,090 | $5,840 | $6,050 | $11,830 | $10,470 |
| Total Assets | $7,740 | $7,020 | $7,840 | $12,110 | $10,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 460 | 410 | 330 | 280 | 260 |
| Accounts payable and accrued liabilities | 5,440 | 4,980 | 5,270 | 0 | 0 |
| Accrued Expenses | 0 | 0 | 0 | 1,530 | 1,230 |
| Other current liabilities | 530 | 390 | 350 | N/A | N/A |
| TOTAL | $6,430 | $5,780 | $5,950 | $1,810 | $1,490 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 20,310 | 10,210 | 10,730 | 10,580 | 10,290 |
| TOTAL | $27,150 | $17,210 | $17,610 | $10,580 | $10,290 |
| Total Liabilities | $33,580 | $22,990 | $23,560 | $12,390 | $11,780 |
| Shareholders' Equity | |||||
| Common Shares | 10,800 | 10,800 | 10,800 | 10,800 | 10,800 |
| TOTAL | $10,800 | $10,800 | $10,800 | $10,800 | $10,800 |
| Total Liabilities And Equity | $44,380 | $33,790 | $34,360 | $23,190 | $22,580 |